Cleared Traditional

K897083 - VENTRESIGN STREP A TEST
(FDA 510(k) Clearance)

Jan 1990
Decision
33d
Days
Class 1
Risk

K897083 is an FDA 510(k) clearance for the VENTRESIGN STREP A TEST. This device is classified as a Antisera, All Groups, Streptococcus Spp. (Class I - General Controls, product code GTZ).

Submitted by Ventrex Laboratories, Inc. (Portland, US). The FDA issued a Cleared decision on January 22, 1990, 33 days after receiving the submission on December 20, 1989.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3740.

Submission Details

510(k) Number K897083 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 1989
Decision Date January 22, 1990
Days to Decision 33 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary

Device Classification

Product Code GTZ — Antisera, All Groups, Streptococcus Spp.
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3740

Similar Devices — GTZ Antisera, All Groups, Streptococcus Spp.

All 104
BINAX NOW STREPTOCOCCUS PNEUMONIAE TEST
K012521 · Binax, Inc. · Nov 2001
UNI-GOLD STREP A TEST KIT
K011709 · Trinity Biotech, Plc · Nov 2001
MODIFICATION TO BINAX NOW STREPTOCOCCUS PNEUMONIAE URINARY ANTIGEN TEST
K010523 · Binax, Inc. · Mar 2001
BINAX NOWR STREPTOCOCCUS PNEUMONIAE URINARY ANTIGEN TEST (22 TEST KIT),(12 TEST KIT), BINAX NOWR STREPTOCOCCUS PNEUMONI
K991726 · Binax, Inc. · Aug 1999
ABBOTT TESTPACK PLUS STREP A WITH ON BOARD CONTROLS (OBC) II
K971522 · Abbott Laboratories · Mar 1998
STREP A OIA MAX
K962060 · Biostar, Inc. · Jul 1997